Annals of Nuclear Medicine

, Volume 18, Issue 3, pp 187–193 | Cite as

A simple method for the detection of abnormal brain regions in Alzheimer’s disease patients using [11C]MP4A: Comparison with [123I]IMP SPECT

  • Tsuneyoshi Ota
  • Hitoshi Shinotoh
  • Kiyoshi Fukushi
  • Shin-ichiro Nagatsuka
  • Hiroki Namba
  • Masaomi Iyo
  • Akiyo Aotsuka
  • Noriko Tanaka
  • Koichi Sato
  • Tetsuya Shiraishi
  • Shuji Tanada
  • Heii Arai
  • Toshiaki Irie
Original article

Abstract

We have developed a radiolabeled lipophilic acetylcholine analogue, N-[11C]methylpiperidin-4-yl acetate ([11C]MP4A) to measure brain acetylcholinesterase (AChE) activity by positron emission tomography (PET)in vivo. Aiming to develop a new SPECT tracer similar to MP4A, we first proposed a simple method for diagnosing Alzheimer’s disease (AD) using [11C]MP4A PET. We performed [11C]MP4A PET and N-isopropyl [123I]iodoamphetamine ([123I]IMP) SPECT in 13 patients with AD and in 17 normal controls (NC). We calculated the ratio of radioactivity of the cortical region of interest (ROI) to that of the cerebellum measured with [11C]MP4A PET (MP4A ratio) and the ratio of regional cerebral blood flow (rCBF) to that of the cerebellum measured with [123I]IMP SPECT (IMP ratio). Eleven cortical ROIs were placed in the frontal, sensorimotor, temporal, parietal, and occipital cortices in both hemispheres and in the posterior cingulate cortex, and z-score was calculated in each ROI in patients with AD compared with NC. When the z-score was 2 or more in a ROI, it was defined as a positive ROI. When a patient had 3 or more positive ROIs, the patient was diagnosed as having AD. The reduction in the MP4A ratio was greater than that in the IMP ratio in all cortical ROIs except for in the right parietal cortex and cingulate cortex in patients with AD. MP4A ratio method showed 92% sensitivity and the IMP ratio method 69% sensitivity for the diagnosis of AD. These results encourage us to develop a new SPECT tracer similar to MP4A for the diagnosis of AD.

Key words

[11C]MP4A PET [123I]IMP SPECT Comparison Alzheimer’s disease simple ratio analysis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.BMJ 1978; 2: 1457–1459.PubMedCrossRefGoogle Scholar
  2. 2.
    Arai H, Kosaka K, Muramoto O, Iizuka R. A biological study of cholinergic neurons in the post-mortem brains from patients with Alzheimer-type dementia.Clin Neurol 1984; 24: 1128–1135.Google Scholar
  3. 3.
    Gsell W, Strein I, Riederer P. The neurochemistry of Alzheimer type, vascular type and mixed type dementias compared.J Neural Transm 1996; 47(Suppl): 73–101.Google Scholar
  4. 4.
    Irie T, Fukushi K, Akimoto Y, Tamagami H, Nozaki T. Design and evaluation of radioactive acetylcholine analogues for mapping brain acetylcholinesterase (AChE)in vivo.Nucl Med Biol 1994; 21: 801–808.PubMedCrossRefGoogle Scholar
  5. 5.
    Tanaka N, Fukushi K, Shinotoh H, Nagatsuka S, Namba H, lyo M, et al. Positron emission tomographic measurement of brain acetylcholinesterase activity using N-[11C]methyl- piperidin-4-yl acetate without arterial blood sampling: Methodology of shape analysis and its diagnostic power for Alzheimer’s disease.J Cereb Blood Flow Metab 2001; 21: 295–301.PubMedCrossRefGoogle Scholar
  6. 6.
    Nagatsuka S, Fukushi K, Shinotoh H, Namba H, lyo M, Tanaka N, et al. Kinetic analysis of [11C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling.J Cereb Blood Flow Metab 2001; 21: 1354–1366.CrossRefGoogle Scholar
  7. 7.
    Kuhl DE, Koeppe RA, Minoshima S, Snyder SE, Ficaro EP, Foster NL, et al.In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer’s disease.Neurology 1999; 52: 691–699.PubMedGoogle Scholar
  8. 8.
    Koeppe RA, Kird A, Frey KA, Snyder P, Meyer MR, Kilbourn, et al. Kinetic modeling of N-[11C]methylpiperidin-4-yl propinate: alternatives for analysis of an irreversible positron emission tomography tracer for measurement of acetylcholinesterase activity in human brain.J Cereb Blood Flow Metab 1999; 19: 1150–1163.PubMedCrossRefGoogle Scholar
  9. 9.
    Ueda T, Irie T, Fukushi K, Ikota N, Takatoku K, Yomoda I, et al.N-methyl-3-(l-hydroxy-5-[123I]iodopent-4-enyl)-4-acetoxypiperidine: A novel candidate of acetylcholinesterase activity imaging agent.J Labelled Cpd Radiopharm 2000; 43: 753–765.CrossRefGoogle Scholar
  10. 10.
    McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease.Neurology 1984; 34: 939–944.PubMedGoogle Scholar
  11. 11.
    Folstein MF, Folstein SE, McHugh PR. “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician.J Psychiatry Res 1975; 12: 189–198.CrossRefGoogle Scholar
  12. 12.
    lyo M, Namba H, Fukushi K, Shinotoh H, Nagatsuka S, Suhara T, et al. Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer’s disease.Lancet 1997; 349: 1805–1809.CrossRefGoogle Scholar
  13. 13.
    Namba H, Yanagisawa M, Yui N, Togawa T, Kinoshita F, Iwadate Y, et al. Quantifying brain tumor blood flow by the microsphere model with N-isopropyl-p-[123I]iodoamphet-amine super-early SPECT.Ann Nucl Med 1996; 10: 161–164.PubMedCrossRefGoogle Scholar
  14. 14.
    Ohkubo M, Odano I, Takahashi N, Takahashi M, Ohtaki H, Noguchi E, et al. A study on accuracy of rCBF measurement using the conventional microsphere method withN-isopropyl-p-iodine-[123I]iodoamphetamine and SPECT.KAKU IGAKU (Jpn J Nucl Med) 1995; 32: 147–151.Google Scholar
  15. 15.
    Namba H, Yanagisawa M, Togawa T, Kinoshita F, Sueyoshi K, Yui N. Quantitative measurement of cerebral blood flow by the microsphere model with super-early123I-IMP brain SPECT.KAKU IGAKU (Jpn J Nucl Med) 1997; 34: 1027–1031.Google Scholar
  16. 16.
    Ikenaga H, Yanagimoto S, Ono S, Tomomitsu T, Mimura H, Morita K, et al. Study of some parameters to calculate regional cerebral blood with microsphere model using N-isopropyl-p-[123l] iodoamphetamine.KAKU IGAKU (Jpn J Nud Med) 1991; 28: 1187–1191.Google Scholar
  17. 17.
    Syed GM, Eagger S, Toone BK, Levy R, Barrett JJ. Quantification of regional cerebral blood flow using99mTc-HMPAO and SPECT: choice of a reference region.Nucl Med Commun 1992; 13: 811–816.PubMedCrossRefGoogle Scholar
  18. 18.
    Varrone A, Soricelli A, Postiglione A, Salvatore M. Comparison between cortical distribution of I-123 iomazenil and Tc-99m HMPAO in patients with Alzheimer’s disease using SPECT.Clin Nucl Med 1999; 24: 660–665.PubMedCrossRefGoogle Scholar
  19. 19.
    Geaney DP, Abou-Saleh MT. The use and applications of single-photon emission computerised tomography in dementia.Br J Psychiatry Suppl 1990; 9: 66–75.PubMedGoogle Scholar
  20. 20.
    Kushner M, Tobin M, Alavi A, Chawluk J, Rosen M, Fazekas F, et al. Cerebellar glucose consumption in normal and pathologic status using fluorine-FDG and PET.J Nucl Med 1987; 28: 1667–1670.PubMedGoogle Scholar
  21. 21.
    Atack JR, Perry EK, Bonham JR, Candy JM, Perry RH. Molecular forms of acetylcholinesterase and butyryl-cho-linesterase in the aged human central nervous system.J Neurochem 1986; 47: 263–277.PubMedGoogle Scholar
  22. 22.
    Jagust W, Thisted R, Devous MD, Van Heertum R, Mayberg H, Jobst K, et al. SPECT perfusion imaging in the diagnosis of Alzheimer’s disease: a clinical-pathologic study.Neurology 2001; 56: 950–956.PubMedGoogle Scholar
  23. 23.
    Scheltens P, Launer LJ, Barkhof F, Weinstein HC, Jonker C. The diagnostic value of magnetic resonance imaging and technetium-99m-HMPAO single photon emission computed tomography for the diagnosis of Alzheimer disease in a community—Dwelling elderly population.Alzheimer Dis Assoc Disord 1997; 11: 63–70.PubMedCrossRefGoogle Scholar
  24. 24.
    Hanyu H, Nakano S, Abe S, Arai H, Iwamoto T, Takasaki M. Neuroimaging in the diagnosis of Alzheimer’s disease.Jpn J Geriat 1994; 31: 683–689.Google Scholar
  25. 25.
    Namba H, lyo M, Shinotoh H, Nagatsuka S, Fukushi K, Irie T. Preserved acetylcholinesterase activity in aged cerebral cortex.Lancet 1998; 351: 881–882.PubMedCrossRefGoogle Scholar
  26. 26.
    Namba H, lyo M, Fukushi K, Shinotoh H, Nagatsuka S, Suhara T, et al. Human cerebral acetylcholinesterase activity measured with positron emission tomography: procedure, normal value and effect of age.Eur J Nucl Med 1999; 26: 135–143.PubMedCrossRefGoogle Scholar
  27. 27.
    Shinotoh H, Aotsuka A, Fukushi K, Nagatsuka S, Tanaka N, Ota T, et al. Effect of donepezil on brain acetylcholinesterase activity in patients with AD measured by PET.Neurology 2001; 56: 408–410.PubMedGoogle Scholar

Copyright information

© Springer 2004

Authors and Affiliations

  • Tsuneyoshi Ota
    • 1
    • 2
  • Hitoshi Shinotoh
    • 1
    • 3
  • Kiyoshi Fukushi
    • 1
  • Shin-ichiro Nagatsuka
    • 1
    • 4
  • Hiroki Namba
    • 5
  • Masaomi Iyo
    • 6
  • Akiyo Aotsuka
    • 1
    • 7
  • Noriko Tanaka
    • 1
    • 8
  • Koichi Sato
    • 1
    • 6
  • Tetsuya Shiraishi
    • 1
    • 6
  • Shuji Tanada
    • 1
  • Heii Arai
    • 2
  • Toshiaki Irie
    • 1
  1. 1.Department of Medical ImagingNational Institute of Radiological SciencesChibaJapan
  2. 2.Department of PsychiatryJuntendo University School of MedicineJapan
  3. 3.Asahi Hospital for Neurological DiseasesJapan
  4. 4.ADME/TOX Research InstituteDaiichi Pure Chemical Co., Ltd.Japan
  5. 5.Department of NeurosurgeryHamamatsu University School of MedicineJapan
  6. 6.Department of PsychiatryChiba University School of MedicineJapan
  7. 7.Department of NeurologyChiba University School of MedicineJapan
  8. 8.Department of NeurosurgeryTokyo Women’s Medical College Daini HospitalJapan

Personalised recommendations